Party branch of pharmaceutical company headquarters organizes theme party day activities
Release time:
2020-07-22
Pharmaceutical Company Headquarters Party Branch Organized Theme Party Day Activities
News 12# July 28 , Pharmaceutical Company Headquarters Party Branch Launches "Remembering Noble Feelings, Firming Ideals and Beliefs " Theme Party Day Activities.
The Party Branch of the Pharmaceutical Company Headquarters organized Party members to visit the former residences of Feng Xuefeng, Wu Han and Ai Qing to learn from the incomparable firmness of the older generation of revolutionaries in their faith, their loyalty to the Party and the people, and the lofty feelings and faith pursuit of "Do not forget your initiative mind, Remember Mission " . Feng Xuefeng, a native of Shintan Village, Yiwu, joined the Communist Party of China in 1927 , 6 , and took part in the Long March in the Red Army's 25,000 in 1934 . Arrested during the Southern Anhui Incident in 1941 . Wu Han is a native of Kuzhutang Village, Wudian Township, Yiwu City. He joined the China Democratic League in 1943 and actively engaged in the democratic movement. After liberation, he served as the deputy mayor of Beijing and a member of the Department of Philosophy and Social Sciences of the Chinese Academy of Sciences. Ai Qing, a native of Jinhua, Zhejiang, and a famous modern poet, joined the Chinese Left-wing Artists League in Shanghai in 1932 to engage in revolutionary literary activities. won the highest medal of French literature and art in 1985 . In the
activity, all party members listened carefully to Feng Xuefeng's advanced deeds, carefully watched relevant historical materials, vivid and touching pictures, photos and precious documents, and made everyone deeply feel Feng Xuefeng "is loyal to the party and dedicated to the people " . All Party members visited Wu Han's former residence and the place where Wu Han lived and studied in those days. They visited and learned about Wu Han's life and deeds in various historical stages and his main works, correspondence and handwritten copies. They felt the original mission of the older generation of revolutionaries on the spot, inherited the red belief, and received re-education of lofty character and upright quality. At Ai Qing's former residence, party members learned about Ai Qing's life story through the photos on display, Ai Qing's poetry collections and the study of Ai Qing's monographs.
Party members recall the extraordinary years of revolutionary martyrs, deeply cherish the great achievements of revolutionary martyrs, further absorb red nutrients, and firmly establish the party's sense of purpose and the concept of the masses. Through unique on-site visits and studies, reviewing the struggle and lofty feelings of the revolutionary ancestors, the hearts of the party members were baptized again, and they all expressed their desire to strengthen their ideals and beliefs and take responsibility for Jianfeng Group to make great achievements. (Wang Fen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page